Tag: Johns Hopkins Bloomberg School of Public Health
10 years on: the legacy of the Flint water crisis
Volume 403, Issue 10437
27 April1 2024
WORLD REPORT The exposure of residents to lead in drinking water caused a national outcry, prompting requirements to update infrastructure and tighten water quality standards. Susan Jaffe reports.
“Flint is making an impact beyond Flint”, said Mona Hanna-Attisha, a Flint paediatrician who collected data on children’s lead blood levels in 2015. “We’re sharing those big lessons—the need to respect science, the need to invest in prevention, the need to pay attention to things like infrastructure and inequities, but also the really amazing lesson of doing something about it.”. [Continued here]…
Sackler money to go towards reducing overdose deaths
Volume 401, Issue 10392 || 10 June 2023
WORLD REPORT A US $6 billion settlement must help to expand treatment access, harm reduction programmes, and recovery services. Susan Jaffe reports.
Federal, state and local governments along with community organisations may soon receive an infusion of US$6 billion to fight the opioid epidemic, including at least $775 million for victims and their families, after a federal appeals court approved a bankruptcy settlement for Purdue Pharma and its founders, the multi-billionaire Sackler family. However, in a controversial move last month, the court also restored protections for the Sacklers from civil lawsuits, despite accusations that their illegal schemes to boost sales of the company’s strongly addictive pain killer, OxyContin (oxycodone), vastly increased their wealth. But without this shield, the agreement would have remained mired in court challenges. [Continued here.] …
US CDC begins agency-wide changes after pandemic failures
Volume 400, Issue 10365
19 November 2022
WORLD REPORT An independent review made several recommendations for improving the public health agency. Susan Jaffe reports from Washington, DC.
Rochelle Walensky: New Director of the US CDC
Volume 397, Issue 10271
14 January 2021
PROFILE Rochelle Walensky
A highly respected researcher, Walensky has published nearly 300 papers, many focused on the cost-effectiveness of HIV interventions and aimed at improving patients’ care. “I call the research that I do policy motivating”, Walensky says. One example is a 2006 landmark study showed that advances in HIV treatment in the USA added nearly 3 million years to patients’ lives.[Full story here.]…
